Dicer deficiency affects microglial function during demyelination and impairs remyelination

Area of Science:

• Neuroscience
• Immunology
• Molecular Biology

Background:

• Microglia are crucial for central nervous system (CNS) homeostasis and repair in demyelinating diseases.
• Dysregulated microglial function exacerbates inflammation and hinders repair in conditions like multiple sclerosis.

Purpose of the Study:

• To investigate the role of Dicer1, essential for microRNA biogenesis, in microglial function during demyelination and remyelination.
• To understand how Dicer1 deficiency impacts inflammatory responses, debris clearance, and oligodendrocyte support.

Main Methods:

• Utilized Dicer1-deficient microglia models.
• Performed transcriptomic analysis to identify affected pathways.
• Validated protein secretion and cellular interactions.
• Assessed effects on oligodendrocyte progenitor cell (OPC) differentiation and oligodendrocyte (OL) survival.

Main Results:

• Dicer1 deficiency in microglia led to heightened inflammation, impaired myelin debris clearance, and disrupted metabolic homeostasis.
• Transcriptomics revealed upregulated inflammatory pathways (interferon signaling, JAK/STAT) and reduced homeostatic gene expression.
• Dicer1-deficient microglia secreted increased pro-inflammatory cytokines (IFN-γ, IL-16, CXCL12), hindering remyelination.
• Failure to support OPC differentiation and increased mature OL apoptosis contributed to remyelination failure.

Conclusions:

• Dicer1 is a critical regulator of microglial homeostasis and inflammation resolution in the CNS.
• Dicer1 deficiency exacerbates demyelination and delays remyelination by promoting chronic inflammation and impairing oligodendrocyte support.
• Targeting Dicer1 in microglia offers a potential therapeutic strategy for demyelinating diseases.